Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
11271 Results
8721
Reviewing state-mandated training requirements for naloxone-dispensing pharmacists
Type: Journal Article
Authors: A. W. Roberts, D. M. Carpenter, A. Smith, K. A. Look
Year: 2019
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
8722
Revising our attitudes towards agonist medications and their diversion in a time of pandemic
Type: Journal Article
Authors: Brandon del Pozo, Josiah D. Rich
Year: 2020
Publication Place: Elmsford
Topic(s):
Opioids & Substance Use See topic collection
8723
Revising the treatment plan and/or ending pain treatment
Type: Book Chapter
Authors: Mark A. Weiner, Herbert L. Malinoff
Year: 2018
Publication Place: New York
Topic(s):
Grey Literature See topic collection
,
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

8725
Revision of the integration of mental health into primary healthcare program and the family physician program
Type: Journal Article
Authors: Jafar Bolhari, Kourosh Kabir, Ahmad Hajebi, Seyed Abas Bagheri Yazdi, Hasan Rafiei, Masoud Ahmadzad Asl, Nilofar Mahdavi Hazave, Mohamadreza Rahbar, Seyed Abbas Motevalian, Hosein Kazemaini
Year: 2016
Topic(s):
General Literature See topic collection
8726
Revisiting Balint's innovation: enhancing capacity in collaborative mental health care
Type: Journal Article
Authors: E. Lee, D. Kealy
Year: 2014
Publication Place: England
Abstract: Interprofessional collaboration is increasingly recognized as a key response to the challenges associated with complex mental health issues in community primary-care settings. Relatively few practice models, however, provide an orientation and a structure that combines quality patient care, professional development, and the building of community capacity. A psychodynamic tradition of supervision and collaboration, an approach known as the Balint model, holds considerable potential to bring this orientation to collaborative primary care and mental health teams. As a consultation group, the Balint approach brings participants' attention to subtle emotional-interpersonal phenomena such as the provider-patient relationship, the presentation of illness, and the experiences of patients and team members. We introduce and provide an overview of the Balint group model, including several concepts proposed by Balint to illuminate the emotional and relational complexities of providing mental health care in a collaborative primary-care setting. The context of our discussion is the implementation of a modified Balint group approach within a Canadian collaborative mental health Care (CMHC) program. We also discuss how an interprofessional application of this approach can enhance patient care, contribute to care providers' professional development, and build community capacity.
Topic(s):
General Literature See topic collection
8727
Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland
Type: Journal Article
Authors: J. A. Cepeda, J. Astemborski, G. D. Kirk, D. D. Celentano, D. L. Thomas, S. H. Mehta
Year: 2019
Abstract:

INTRODUCTION: Prescription drug abuse is a major public health problem in rural and suburban areas of the United States, however its emergence in large urban settings with endemic injection drug use remains understudied. We examined temporal trends in injection drug use initiation and mortality among people who inject drugs (PWID) in Baltimore, Maryland. METHODS: Data were derived from the baseline assessment of PWID enrolled in a community-based cohort study with longitudinal follow-up for mortality assessment. PWID were recruited from 2005-2008 (N = 1,008) and 2015-2018 (N = 737). We compared characteristics by birth cohort (before/after 1980) and type of drug initiated (prescription opioids, prescription non-opioids, non-injection illicit drugs, or injection drugs). We calculated standardized mortality ratios (SMR) using the US general population as the reference. RESULTS: PWID born after 1980 were more likely to initiate drug use with prescription opioids and non-opioids and had higher levels of polysubstance prior to injection initiation, compared to individuals born before 1980. Overall mortality was high: 2.59 per 100 person-years (95% CI: 2.27-2.95 per 100 person-years). Compared to the US population, the highest SMRs were observed among participants between 40-44 years of age, with especially high mortality among women in this age group (SMR:29.89, 95% CI: 15.24-44.54). CONCLUSIONS: Mirroring national trends, the profile of PWID in Baltimore has changed with increased prescription drug abuse and high levels of polysubstance use among younger PWID. Interventions need to reach those using prescription drugs early after initiation of use in order to reduce transition to injecting. Urgent attention is warranted to address premature mortality, particularly among middle-aged and female PWID.

Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
8728
Risk Adjustment for Primary Care: An Essential Tool for Health System Reform.
Type: Journal Article
Authors: Allan H. Goroll
Year: 2012
Topic(s):
Financing & Sustainability See topic collection
,
Measures See topic collection
8729
Risk and protective factors of current opioid use among youth living on or near American Indian reservations: An application of machine learning
Type: Journal Article
Authors: Mark A. Prince, Bradley T. Conner, Samuel R. Davis, Randall C. Swaim, Linda R. Stanley
Year: 2021
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8730
Risk assessment practice within primary mental health care: A logics perspective
Type: Journal Article
Authors: Adam Flintoff, Speed Ewen, Susan McPherson
Year: 2019
Publication Place: London
Topic(s):
General Literature See topic collection
8731
Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature
Type: Journal Article
Authors: R. M. Lyons, A. M. Yule, D. Schiff, S. M. Bagley, T. E. Wilens
Year: 2019
Abstract:

Objectives: Drug overdose (OD) deaths have been increasing over the past 20 years. Although risk factors for drug OD have been identified in adult populations, less is known about risk factors for OD in young people. The aim of this review is to systematically examine the literature to identify risk factors for drug OD specific to young people, including adolescents and young adults. Methods: Our initial PubMed search identified 4001 articles. Included were cross-sectional and longitudinal cohort studies published in English that compared young people who experienced a drug OD to those who did not. Review articles, meta-analyses, case-reports, editorials, epidemiological studies, and qualitative studies were excluded. Two investigators reviewed the full texts of all relevant articles and extracted data on sample demographics, prevalence of OD, and correlates associated with OD. Results: Twelve relevant studies were identified reflective of a sample of 5020 unique individuals with an age range of 14-30 years, and a mean age range of 20.2-26 years. The lifetime prevalence of OD in these young people ranged from 24% to 48%. Substance use characteristics most often associated with OD included injection drug, opioid, and tranquilizer use. Polysubstance use was also found to be strongly associated with OD in three studies. Other replicated risk factors for OD in young people included histories of psychopathology, incarceration, unstable housing, and witnessing an OD. Conclusion: Opioid, tranquilizer, and injection drug use have been identified as risk factors for OD in both younger and older adult populations. Risk factors that emerged as noteworthy predictors of OD in young people specifically include polysubstance use, psychiatric comorbidity, unstable housing, and witnessing an OD. There remains a paucity of literature on drug OD risk factors in young people, with little information regarding medical and treatment history risk factors.

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8732
Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain
Type: Journal Article
Authors: C. M. Wilder, S. C. Miller, E. Tiffany, T. Winhusen, E. L. Winstanley, M. D. Stein
Year: 2016
Publication Place: England
Abstract: Rising overdose fatalities among U.S. veterans suggest veterans taking prescription opioids may be at risk for overdose. However, it is unclear whether veterans prescribed chronic opioids are aware of this risk. The objective of this study was to identify risk factors and determine awareness of risk for opioid overdose in veterans treated with opioids for chronic pain, using veterans treated with methadone or buprenorphine for opioid use disorder as a high-risk comparator group. In the current study, 90 veterans on chronic opioid medication, for either opioid use disorder or pain management, completed a questionnaire assessing risk factors, knowledge, and self-estimate of risk for overdose. Nearly all veterans in both groups had multiple overdose risk factors, although individuals in the pain management group had on average a significantly lower total number of risk factors than did individuals in the opioid use disorder group (5.9 versus 8.5, p < .0001). On average, participants treated for pain management scored slightly but significantly lower on knowledge of opioid overdose risk factors (12.1 versus 13.5, p < .01). About 70% of participants, regardless of group, believed their overdose risk was below that of the average American adult. There was no significant relationship between self-estimate of overdose risk and either number or knowledge of opioid overdose risk factors. Our results suggest that veterans in both groups underestimated their risk for opioid overdose. Expansion of overdose education to include individuals on chronic opioids for pain management and a shift in educational approaches to overdose prevention may be indicated.
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8735
Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study
Type: Journal Article
Authors: K. F. Huybrechts, B. T. Bateman, R. J. Desai, S. Hernandez-Diaz, K. Rough, H. Mogun, L. S. Kerzner, J. M. Davis, M. Stover, D. Bartels, J. Cottral, E. Patorno
Year: 2017
Publication Place: England
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
8736
Risk of overdose‐related death for people with a history of incarceration
Type: Journal Article
Authors: Wen Qi Gan, Stuart A. Kinner, Tonia L. Nicholls, Chloé G. Xavier, Karen Urbanoski, Leigh Greiner, Jane A. Buxton, Ruth E. Martin, Katherine E. McLeod, Hasina Samji, Seonaid Nolan, Louise Meilleur, Roshni Desai, Soha Sabeti, Amanda K. Slaunwhite
Year: 2021
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8737
Risk of Persistence and Progression of Use of 5 Cannabis Products After Experimentation Among Adolescents
Type: Journal Article
Authors: J. L. Barrington-Trimis, J. Cho, E. Ewusi-Boisvert, D. Hasin, J. B. Unger, R. A. Miech, A. M. Leventhal
Year: 2020
Abstract:

IMPORTANCE: While a diverse array of cannabis products that may appeal to youth is currently available, it is unknown whether the risk of persistent cannabis use and progression to higher frequency of use after experimentation differs among cannabis products. OBJECTIVE: To estimate the comparative relative risk of experimental use of 5 cannabis products on use status and frequency of use among adolescents during 12 months of follow-up. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, data were collected from 3065 adolescents at 10 high schools in southern California, with baseline data collected in spring 2016, when students were in 11th grade, and 6-month and 12-month follow-up surveys collected in fall 2016 and spring 2017, when students were in 12th grade. Analyses, conducted from April to June 2019, were restricted to 2685 participants who were light or nonusers of any cannabis product (ie, ≤2 days in the past 30 days) at baseline. EXPOSURES: Number of days of use of each cannabis product (ie, combustible, blunts, vaporized, edible, or concentrated) in the past 30 days at baseline (ie, 1-2 vs 0 days). MAIN OUTCOMES AND MEASURES: Past 6-month use (ie, yes vs no) and number of days of use in the past 30 days at 6-month and 12-month follow-ups for each product. RESULTS: Of 2685 individuals in the analytic sample, 1477 (55.0%) were young women, the mean (SD) age was 17.1 (0.4) years, and a plurality (1231 [46.6%]) were Hispanic individuals. Among them, 158 (5.9%) reported combustible cannabis use on 1 to 2 days of the past 30 days at baseline, 90 (3.4%) reported blunt use, 78 (2.9%) reported edible cannabis use, 17 (0.6%) reported vaping cannabis, and 15 (0.6%) reported using cannabis concentrates. In regression models adjusting for demographic characteristics and poly-cannabis product use, statistically stronger associations of baseline use with subsequent past 6-month use at the 6-month and 12-month follow-ups were observed for combustible cannabis use (odds ratio, 6.01; 95% CI, 3.66-9.85) and cannabis concentrate use (odds ratio, 5.87; 95% CI, 1.18-23.80) compared with use of blunts (OR, 2.77; 95% CI, 1.45-5.29) or edible cannabis (OR, 3.32; 95% CI, 1.86-5.95) (P for comparison < .05); vaporized cannabis use (OR, 5.34; 95% CI, 1.51-11.20) was not significantly different from the other products. In similarly adjusted models, we found the association of cannabis use at baseline with mean days of use at the 6-month and 12-month follow-ups was significantly stronger for cannabis concentrate than for other cannabis products; participants who had used cannabis concentrate on 1 to 2 of the past 30 days at baseline (vs 0 days) used cannabis concentrate a mean of 9.42 (95% CI, 2.02-35.50) more days in the past 30 days at the 6-month and 12-month follow-ups (P for comparison < .05). CONCLUSIONS AND RELEVANCE: Cannabis control efforts should consider targeting specific cannabis products, including combustible cannabis and cannabis concentrate, for maximum public health consequences.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8739
Risk perceptions and recovery threats for clients with a history of methadone maintenance therapy dropout
Type: Journal Article
Authors: Geoffrey Maina, Layane Fernandes de Sousa, Solomon Mcharo, Sarah Kiburi
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection